Hilary Wall
Principal Biostatistician
Hilary Wall
Principal Biostatistician
Hilary Wall holds advanced degrees in Statistics and Biomedical Statistics. She has over 12 years of experience writing detailed statistical analysis plans, specifying and performing statistical analyses, preparing displays and reports, communicating with sponsors, and providing safety evaluations for data monitoring committees. Since her beginning at Rho in 2007, she has led the biostatistics and statistical programming teams, providing analysis support for many protocols and several ISS/ISEs. She has led and participated in numerous NDA submissions in which she designed and implemented the integrated analysis database across multiple studies for both the Integrated Summary of Safety and Integrated Summary of Efficacy. Ms.Wall has collaborated with researchers in several areas including autism, rheumatoid arthritis, atrial fibrillation, Alzheimer’s disease, asthma, cystic fibrosis, hepatitis C, overactive bladder, oncology, otitis media, NASH, and pruritus.
Content by Hilary Wall
Blog Post
Should I up-version study SDTM and ADaM when it becomes time to submit a marketing application?
Do I need to up-version to the most recent versions of the standard from the current Catalog when preparing to submit clinical study data? How can I figure this out? Check out the latest blog from Rho to find out.